NPs Basic Information

Name
Citronellol
Molecular Formula C10H20O
IUPAC Name*
3,7-dimethyloct-6-en-1-ol
SMILES
CC(CCC=C(C)C)CCO
InChI
InChI=1S/C10H20O/c1-9(2)5-4-6-10(3)7-8-11/h5,10-11H,4,6-8H2,1-3H3
InChIKey
QMVPMAAFGQKVCJ-UHFFFAOYSA-N
Synonyms
Citronellol; 106-22-9; 3,7-Dimethyloct-6-en-1-ol; beta-Citronellol; DL-Citronellol; Cephrol; 6-Octen-1-ol, 3,7-dimethyl-; 3,7-DIMETHYL-6-OCTEN-1-OL; Elenol; Rodinol; 2,3-Dihydrogeraniol; 2,6-Dimethyl-2-octen-8-ol; (+/-)-beta-Citronellol; Citronellol, dl-; .beta.-Citronellol; Dihydrogeraniol; 26489-01-0; (+/-)-3,7-dimethyloct-6-en-1-ol; CHEBI:50462; NSC 8779; 565OK72VNF; 3,7-dimethyl-oct-6-en-1-ol; NSC8779; NSC-8779; D-Citronellol;(R)-(+)-beta-Citronellol; (+/-)-Citronellol;(+/-)-beta-Citronellol; DSSTox_CID_6726; DSSTox_RID_78201; DSSTox_GSID_26726; 68916-43-8; CAS-106-22-9; (+/-)-beta-Citronellol analytical standard; Citronellol (natural); (+-)-beta-citronellol; (+-)-CITRONELLOL; (R)-(+)-.beta.-Citronellol; UNII-565OK72VNF; (+/-)-beta-Citronellol, primary pharmaceutical reference standard; CCRIS 7452; Levo-citronellol; MFCD00063214; Citronellol Natural; EINECS 203-375-0; EINECS 247-737-6; MFCD00002935; BRN 1721507; ST069325; AI3-25080; beta-Citronellol, 95%; (+-)-beta;-Citronellol; EC 203-375-0; SCHEMBL21320; (S)-(-)-|A-Citronellol; 4-01-00-02188 (Beilstein Handbook Reference); 6-Octen-1-ol,7-dimethyl-; MLS002415719; 3,7-dimethyl-oct-6-en1-ol; CHEMBL395827; DTXSID3026726; CITRONELLOL, (+/-)-; HSDB 6805; .BETA.-CITRONELLOL [MI]; WLN: Q2Y1&3UY1&1; HMS2267B17; Citronellol, >=95%, FCC, FG; Tox21_202119; Tox21_300003; (+/-)-.BETA.-CITRONELLOL; BBL009826; BDBM50037035; s5584; STK085542; AKOS005393175; CCG-266265; CS-W010917; HY-W010201; (+/-)-3,7-dimethyl-6-octen-1-ol; .BETA.-CITRONELLOL, (+/-)-; NCGC00091348-01; NCGC00091348-02; NCGC00091348-03; NCGC00091348-04; NCGC00254145-01; NCGC00259668-01; AS-14688; BP-21491; SMR000112138; SY066737; ( inverted exclamation markA)-b-Citronellol; DB-060123; DB-074976; (+/-)-beta-Citronellol, analytical standard; FT-0604381; FT-0622896; FT-0623965; FT-0623966; FT-0693159; FT-0772868; 6-Octen-1-ol, 3,7-dimethyl-, (+/-)-; EN300-1270486; W-108771; W-109198; W-110227; Q27122080
CAS 106-22-9
PubChem CID 8842
ChEMBL ID CHEMBL395827
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Prenol lipids
        • Subclass: Monoterpenoids
          • Direct Parent: Acyclic monoterpenoids

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 156.26 ALogp: 3.2
HBD: 1 HBA: 1
Rotatable Bonds: 5 Lipinski's rule of five: Accepted
Polar Surface Area: 20.2 Aromatic Rings: 0
Heavy Atoms: 11 QED Weighted: 0.603

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.252 MDCK Permeability: 0.00001980
Pgp-inhibitor: 0.006 Pgp-substrate: 0.006
Human Intestinal Absorption (HIA): 0.005 20% Bioavailability (F20%): 0.55
30% Bioavailability (F30%): 0.101

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.948 Plasma Protein Binding (PPB): 93.48%
Volume Distribution (VD): 2.272 Fu: 6.41%

ADMET: Metabolism

CYP1A2-inhibitor: 0.65 CYP1A2-substrate: 0.427
CYP2C19-inhibitor: 0.092 CYP2C19-substrate: 0.604
CYP2C9-inhibitor: 0.052 CYP2C9-substrate: 0.765
CYP2D6-inhibitor: 0.007 CYP2D6-substrate: 0.115
CYP3A4-inhibitor: 0.018 CYP3A4-substrate: 0.162

ADMET: Excretion

Clearance (CL): 12.891 Half-life (T1/2): 0.593

ADMET: Toxicity

hERG Blockers: 0.018 Human Hepatotoxicity (H-HT): 0.573
Drug-inuced Liver Injury (DILI): 0.028 AMES Toxicity: 0.004
Rat Oral Acute Toxicity: 0.01 Maximum Recommended Daily Dose: 0.021
Skin Sensitization: 0.857 Carcinogencity: 0.224
Eye Corrosion: 0.915 Eye Irritation: 0.985
Respiratory Toxicity: 0.045
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC000229 0.600 D0M1PQ 0.486
ENC000319 0.571 D05XQE 0.254
ENC000230 0.568 D0Y3KG 0.250
ENC003366 0.478 D0C1QZ 0.211
ENC000396 0.424 D09XWD 0.205
ENC000846 0.400 D0ZK8H 0.195
ENC001150 0.391 D03VFL 0.189
ENC000804 0.358 D00WUF 0.188
ENC002844 0.346 D03CHT 0.184
ENC000796 0.346 D00FSV 0.176
*Note: the compound similarity was calculated by RDKIT.